Notoginsenoside R1 Alleviates Macrophage Inflammatory Responses via Modulating the JAK1/STAT3 Pathway
Journal of Cellular Biochemistry · 2026-08 · 127 (8)
DOI: 10.1002/jcb.70112 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cellular Biochemistry, online erschienen am 29.07.2026. Verfasst von Chengjie Wu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Shaoxing People's Hospital, Shaoxing, China. Hauptthemen laut MEDLINE: Ginsenosides, STAT3 Transcription Factor, Janus Kinase 1, Macrophages. Die Arbeit nennt 22 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Zhejiang Provincial Health Science and Technology Plan, Zhejiang Provincial Traditional Chinese Medicine Science and Technology Project, Shaoxing Municipal Science and Technology Project.
Abstract (Originalsprache)
Notoginsenoside R1 (NR1), an active component of Panax notoginseng , may exert anti‐atherosclerotic effects by modulating macrophage M1/M2 polarization. This study aimed to investigate the specific mechanism of NR1 against atherosclerosis based on the JAK1/STAT3 pathway. M1 and M2 macrophage models, as well as an ox‐LDL‐induced macrophage model, were established. These models were treated with varying concentrations of NR1. Our results demonstrated that NR1 effectively suppressed LPS/IFN‐γ or ox‐LDL‐induced polarization of macrophages toward the pro‐inflammatory M1 phenotype and promoted their transition to the anti‐inflammatory M2 phenotype. Concurrently, NR1 significantly inhibited the phagocytosis of ox‐LDL by macrophages in the atherosclerosis model, reduced lipid accumulation, and improved mitochondrial function. Mechanistically, the regulatory effects of NR1 on macrophage polarization and function primarily depended on the inhibition of the JAK1/STAT3 signaling pathway. In conclusion, this study suggests that NR1 targets the JAK1/STAT3 pathway to balance macrophage M1/M2 polarization, thereby suppressing inflammatory responses, and ultimately alleviating atherosclerosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Shaoxing People's Hospital, Shaoxing, China.
- The First Hospital of Shaoxing University, Shaoxing, China.
- Traditional Chinese Medical Hospital of Zhuji, Zhuji, China.
- Shaoxing TCM Hospital Affiliated to Zhejiang Chinese Medical University, Shaoxing, China.
ORCID-Profile: Chengjie Wu
Förderung
- Zhejiang Provincial Health Science and Technology Plan
- Zhejiang Provincial Traditional Chinese Medicine Science and Technology Project
- Shaoxing Municipal Science and Technology Project
Zitieren
APA
Wu, C., Hou, S., Liu, M., Feng, H., Jiang, X., Ji, N., & Fang, F. (2026). Notoginsenoside R1 Alleviates Macrophage Inflammatory Responses via Modulating the JAK1/STAT3 Pathway. Journal of Cellular Biochemistry, 127(8). https://doi.org/10.1002/jcb.70112
Vancouver
Wu C, Hou S, Liu M, Feng H, Jiang X, Ji N, et al. Notoginsenoside R1 Alleviates Macrophage Inflammatory Responses via Modulating the JAK1/STAT3 Pathway. Journal of Cellular Biochemistry. 2026;127(8). doi:10.1002/jcb.70112
BibTeX
@article{Wu2026,
author = {Wu, Chengjie and Hou, Shuting and Liu, Meizhi and Feng, Hualin and Jiang, Xu and Ji, Nengneng and Fang, Fang},
title = {Notoginsenoside R1 Alleviates Macrophage Inflammatory Responses via Modulating the JAK1/STAT3 Pathway},
journal = {Journal of Cellular Biochemistry},
year = {2026},
volume = {127},
number = {8},
doi = {10.1002/jcb.70112}
}
EUVIMED